Results of SAVANNAH Global Phase II Trial at WCLC
Shares Magazine,
Press Release - 49% ORR amongst SAVANNAH patients with higher MET levels - Hong Kong, Shanghai & Florham Park, NJ - Wednesday…
Press Release - 49% ORR amongst SAVANNAH patients with higher MET levels - Hong Kong, Shanghai & Florham Park, NJ - Wednesday…
In 2011, following its discovery and initial development by HUTCHMED, AstraZeneca and HUTCHMED entered a global licensing and…
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., July 12, 2022 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Na…
Please enter a search term. Please enter a search term. News provided by Jul 12, 2022, 8:00 PM ET HONG KONG and SHANGHAI, China…